Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.49 |
| ▸ | LPL | P06858 | 6/20 | 0.49 |
| ▸ | TYR | P14679 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29591190 | 1.00 | LIPG (0.49) | LIPGLPLTYRALOX5TDP1 | |
| SCHEMBL4267973 | 1.00 | LIPG (0.49) | LIPGLPLTYRALOX5TDP1 | |
| SCHEMBL18025836 | 0.92 | LIPG (0.55) | LIPGLPLTYRALOX5TDP1 | |
| SCHEMBL12234041 | 0.92 | LIPG (0.55) | LIPGLPLTYRALOX5TDP1 | |
| SCHEMBL1336781 | 0.92 | LIPG (0.55) | LIPGLPLTYRALOX5TDP1 | |
| SCHEMBL16682948 | 0.86 | LPL (0.47) | LIPGLPLTYR | |
| SCHEMBL15759747 | 0.83 | LPL (0.38) | LIPGLPL | |
| SCHEMBL24297913 | 0.82 | LPL (0.46) | LIPGLPLTYRALOX5TDP1 | |
| SCHEMBL24634580 | 0.80 | LPL (0.44) | LIPGLPLTDP1ALOX15TSHR | |
| SCHEMBL12020061 | 0.80 | LPL (0.44) | LIPGLPLTYRALOX5TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2023-08-15 | — | — | US | disclosed |
| US-9929347-B2 | Polymer compound and light emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9837612-B2 | Polymer compound and light-emitting device using same | SUMITOMO CHEMICAL COMPANY, LIMTED (JP) | 2017-12-05 | — | — | US | disclosed |
| WO-2017103610-A1 | DOPANT, CHARGE TRANSFER SALT AND ORGANIC ELECTRONIC DEVICE | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017103609-A1 | CHARGE TRANSFER SALT, ELECTRONIC DEVICE AND METHOD OF FORMING THE SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-06-22 | — | — | WO | disclosed |
| US-20160218291-A1 | POLYMER AND ORGANIC LIGHT EMITTING DEVICE | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2016-07-28 | — | — | US | disclosed |
| US-20150115204-A1 | POLYMER COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-04-30 | — | — | US | disclosed |
| WO-2015044656-A1 | POLYMER AND ORGANIC LIGHT EMITTING DEVICE | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CHRM1, SLC6A3, DRD1 | LIPG 4281/4885LPL 4703/4885TYR 6/4885 |
| US-20150115204-A1 | POLYMER COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | NAP1L4, AHR, NR0B1 | LIPG 2045/4885LPL 365/4885TYR 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.